CoChat

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

Open access
Clayton, T. Andrew, Baker, David, Lindon, John C., Everett, Jeremy R., Nicholson, Jeremy K. · 2009 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

We provide a demonstration in humans of the principle of pharmacometabonomics by showing a clear connection between an individual's metabolic phenotype, in the form of a predose urinary metabolite profile, and the metabolic fate of a standard dose of the widely used analgesic acetaminophen. Predose and postdose urinary metabolite profiles were determined by 1 H NMR spectroscopy. The predose spectra were statistically analyzed in relation to drug metabolite excretion to detect predose biomarkers of drug fate and a human-gut microbiome cometabolite predictor was identified. Thus, we found that individuals having high predose urinary levels of p -cresol sulfate had low postdose urinary ratios of acetaminophen sulfate to acetaminophen glucuronide. We conclude that, in individuals with high bacterially mediated p -cresol generation, competitive O-sulfonation of p -cresol reduces the effective systemic capacity to sulfonate acetaminophen. Given that acetaminophen is such a widely used and seemingly well-understood drug, this finding provides a clear demonstration of the immense potential and power of the pharmacometabonomic approach. However, we expect many other sulfonation reactions to be similarly affected by competition with p -cresol and our finding also has important implications for certain diseases as well as for the variable responses induced by many different drugs and xenobiotics. We propose that assessing the effects of microbiome activity should be an integral part of pharmaceutical development and of personalized health care. Furthermore, we envisage that gut bacterial populations might be deliberately manipulated to improve drug efficacy and to reduce adverse drug reactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0904489106

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 765

Metadata

Authors
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K.
Affiliations
  • Imperial College London (GB)
  • Pfizer (United States) (US)
  • Pfizer (United Kingdom) (GB)
Corresponding author
Nicholson, Jeremy K.
Venue
Proceedings of the National Academy of Sciences
Published
2009-08-25
Volume
106
Issue
34
Pages
14728-14733
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2061156796
Cited by
765
References
76
Citations by year
2026: 18 · 2025: 29 · 2024: 31 · 2023: 40 · 2022: 38 · 2021: 51 · 2020: 68 · 2019: 54 · 2018: 38 · 2017: 44 · 2016: 70 · 2015: 54 · 2014: 48 · 2013: 44 · 2012: 53
FWCI
40.82
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Imperial College London
  • King's College London
  • Wuhan University
  • Medical Research Council
  • Royal Holloway, University of London
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
acetaminophen metabolism, gut microbiota, host-microbiome interactions, p-cresyl sulfate, acetaminophen sulfate, acetaminophen glucuronide, personalized medicine, drug metabolism variability
MeSH terms
Acetaminophen, Administration, Oral, Adolescent, Adult, Bacteria, Cresols, Humans, Male, Middle Aged, Magnetic Resonance Spectroscopy, Sulfates, Sulfuric Acid Esters, Analgesics, Non-Narcotic, Gastrointestinal Tract, Host-Pathogen Interactions, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.